Concord Wealth Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12
| Closed | -$1K | – | 901 |
|
|
2022
Q2 | $1K | Sell |
12
-50
| -81% | -$4.17K | ﹤0.01% | 1181 |
|
|
2022
Q1 | $5K | Hold |
62
| – | – | ﹤0.01% | 919 |
|
|
2021
Q4 | $5K | Buy |
62
+50
| +417% | +$4.03K | ﹤0.01% | 959 |
|
|
2021
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 859 |
|
|
2021
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 1000 |
|
|
2021
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 944 |
|
|
2020
Q4 | $2K | Buy |
+12
| New | +$2K | ﹤0.01% | 560 |
|